MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Integrating Transcriptomics and Morphological Profiling to Characterize GBA-Associated Parkinson’s Disease in Midbrain Organoids

    F. Nasta, E. Glaab, JC. Schwamborn (Esch-sur Alzette, Luxembourg)

    Objective: This study characterizes converging biological trends in GBA-associated Parkinson’s Disease by integrating transcriptomic profiling with exploratory image-based analysis of donor-matched midbrain organoids. Background: High-content…
  • 2026 International Congress

    Therapeutic Efficacy of a Next-Generation 16-Contact Directional Deep Brain Stimulation System in Parkinson’s Disease

    F. Morgante, C. Matthies, S. Vinke, R. Schuurman, V. Visser-Vandewalle, A. Gharabaghi, V. Coenen, J. Fitzgerald, D. Pedrosa, A. Kühn, C. Mertz, L. Chen, R. Shivacharan, E. Goldberg (London, United Kingdom)

    Objective: We assessed the clinical efficacy and safety of a novel deep brain stimulation (DBS) system equipped with 16-contact directional leads in improving motor symptoms…
  • 2026 International Congress

    Modeling the Genetic Complexity of Parkinson’s Disease: Generation of Patient-Specific iPSCs with Co-occurring SNCA/GBA1 and PRKN/LRRK2 Variants

    L. Murillo-Hernández, M. Bonilla-Toribio, D. Buiza-Rueda, P. Gomez-Garre, L. Muñoz-Delgado, P. Mir, R. Mejías, A. Fontán-Lozano (Sevilla, Spain)

    Objective: This study aimed to generate and characterize human induced pluripotent stem cell (iPSC) lines derived from two Parkinson’s Disease (PD) patients carrying combinations of…
  • 2026 International Congress

    Early-Onset Parkinson’s Disease with Early Peak-Dose Dyskinesia: A Case Report

    VD. Tkachenko, MZ. Makoeva, MR. Portnova, AV. Nikitina (Moscow, Russian Federation)

    Objective: To present a case of early-onset Parkinson's disease (EOPD) in a 41-year-old male with good levodopa response but complicated by early development of peak-dose…
  • 2026 International Congress

    Evaluating YouTube as a source of health information on Parkinson’s disease

    KJ. Baladjay, LM. Bagares, RD. Jamora (Manila, Philippines)

    Objective: This study aimed to evaluate the quality, reliability, and engagement characteristics of YouTube videos on Parkinson's disease using standardized assessment tools. Background: Parkinson’s disease…
  • 2026 International Congress

    Feasibility of Remote Identification of Catatonia Across Different Motor Presentations

    N. Kadubandi, A. Elshourbagy, A. Tasmiya, M. van Emdeboas, R. Aydin, A. Epstein, R. Guo, L. Smith, N. Li, J. Barnett, J. Brasic (Baltimore, USA)

    Objective: To evaluate the feasibility of the identification of catatonia by trained raters through remote viewing of motor assessments across patients with differing motor profiles…
  • 2026 International Congress

    Prevalence and associated factors of sarcopenia among Thai patients with ambulatory Parkinson’s disease

    J. Intum, P. Lolekha, K. Chupisanyarote (Khlong Luang, Thailand)

    Objective: Objectives: To determine the prevalence of Asian Working Group for Sarcopenia (AWGS) 2019-defined sarcopenia phenotypes, identify associated factors, and evaluate screening performance in Thai PD patients. Background: Sarcopenia is…
  • 2026 International Congress

    Healthcare Professionals’ Perceptions of using eHealth in the Rehabilitation of Progressive Disease: A Qualitative Study

    B. Leavy, C. Quinn, C. Malinowsky, H. Johansson (Huddinge, Sweden)

    Objective: This study aimed to explore the perceptions of occupational therapists and physical therapists, working in primary care settings, concerning the use of eHealth methods…
  • 2026 International Congress

    Neuropsychiatric Symptom Evolution Over the First Decade of Biomarker-Defined Parkinson’s Disease

    I. Schoen, J. Wang, S. Xie, C. Caspell-Garcia, E. Mamikonyan, M. Stark, N. Dahodwala, A. Siderowf, R. Dobkin, M. York, D. Weintraub (Philadelphia, USA)

    Objective: To examine the evolution of neuropsychiatric symptoms (NPS) in biomarker-defined Parkinson’s disease over the first decade following diagnosis. Background: Parkinson’s disease (PD) is frequently…
  • 2026 International Congress

    Opicapone as adjunct to levodopa in Chinese patients with Parkinson’s disease and wearing-off: a randomized, double-blind, placebo-controlled phase 3 trial

    S. Chen, Y. Tan (Shanghai, China)

    Objective: To evaluate the efficacy and safety of once-daily opicapone as adjunct to levodopa in Chinese patients with Parkinson’s disease (PD) and wearing-off, and to…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley